1. Home >
  2. M&A >
  3. Stake Purchase >
  4. South Korea >
  5. Huons Invests In PanGen

Investment Summary

Huons Invests In PanGen

On November 7, 2024, Huons invested in life science company PanGen

Investment Highlights
  • This is Huons’ 1st transaction in the Life Science sector.
  • This is Huons’ 1st transaction in South Korea.

Investment Summary
Date 2024-11-07
Target PanGen
Sector Life Science
Investor(s) Huons
Deal Type Stake Purchase

Target

PanGen

Suwon-si, South Korea
PanGen is a raw material producer of human hyaluronidase, signed an entrustment contract with Huonslab, a Huons subsidiary, to produce clinical samples for ‘human hyaluronidase’ and conduct validation for product approval. was founded in 1999 and is based in Suwon-si, South Korea.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Huons

Seongnam-si, South Korea
Category Company
Founded 1965
Sector Life Science
Revenue 590.2B KRW (2024)
DESCRIPTION

Huons provides medical solutions for human health. The company functions through three divisions: pharmaceuticals, medical devices, and cosmetics. Huons was founded in 1965 and is headquartered in Seongnam-si, South Korea.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: South Korea M&A 1 of 1
Year: 2024 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal